EB

Ekta Bhagvanbhai Vala

Active Director Designated Partner DIN 09084279
DIN 09084279 First appointment Feb 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ekta Bhagvanbhai Vala

Data last updated:

Ekta Bhagvanbhai Vala is a Designated Partner at Medisquare Super Speciality Hospital Llp (since 2021). The company operates in Healthcare.

DIN 09084279
Primary Designation Designated Partner
Industry Healthcare
First Appointment 26 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Feb 20212021Active

Board colleagues of Ekta Bhagvanbhai Vala

Directorship timeline

Open interactive timeline →
Medisquare Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Ekta Bhagvanbhai Vala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ekta Bhagvanbhai Vala

Ekta Bhagvanbhai Vala currently holds 1 directorship: Medisquare Super Speciality Hospital Llp (Designated Partner, since 26 Feb 2021).

Ekta Bhagvanbhai Vala was first appointed on 26 Feb 2021 as Designated Partner at Medisquare Super Speciality Hospital Llp.

The current boards of Ekta Bhagvanbhai Vala's companies include Harshaben Vinodray Chandarana (Medisquare Super Speciality Hospital Llp), Shilpaben Ghanshyambhai Patel (Medisquare Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available